RxDoctor Payments Data

Melanie Morris

Nurse Practitioner · Houston, TXNPI 1548347636

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $248,638 of the $254,100 with a category attached, or 97.9%. Galderma Laboratories, L.p. accounts for 99.5% of it on its own, with 3 other manufacturers making up the rest. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$254,100in general payments, 2019–2025

Across 233 payments — averaging $1090.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$253K
  • AbbVie$1K
  • Revance Therapeutics, Inc.$121
  • Boston Scientific$27

What the payments were for

  • Consulting fees$7540%
  • Speaking & faculty fees$248,63898%
  • Travel & lodging$2,3071%
  • Food & beverage$2,4011%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.208$252,744
AbbVie(2 entities)20$1,209
Revance Therapeutics, Inc.4$121
Boston Scientific1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$254,100 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas →

Other nurse practitioner in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →